Free Trial
NYSEARCA:HRTS

Tema Obesity & Cardiometabolic ETF (HRTS) Price, Holdings, & News

$29.15 +0.08 (+0.28%)
(As of 12/20/2024 05:40 PM ET)

About Tema Obesity & Cardiometabolic ETF (NYSEARCA:HRTS)

Key Stats

Today's Range
$28.90
$29.52
50-Day Range
$29.07
$34.41
52-Week Range
$28.81
$36.03
Volume
10,013 shs
Average Volume
23,112 shs
Market Capitalization
$55.09 million
Assets Under Management
$524,000.00
Dividend Yield
N/A
Net Expense Ratio
0.00%
Aggregate Rating
Moderate Buy

ETF Overview

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.

Tema Obesity & Cardiometabolic ETF Expenses

TypeHRTSNYSEARCA ETFsAll ETFs
Management Fee0.00%0.51%0.52%
Other Expenses0.00%0.57%0.53%
Total Expense0.00%0.73%0.71%
Fee Waiver0.00%-0.67%-0.56%
Net Expense0.00%0.58%0.59%
Receive HRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tema Obesity & Cardiometabolic ETF and its competitors with MarketBeat's FREE daily newsletter.

HRTS ETF News Headlines

HRTS: Generating Alpha In Obesity Treatment
Wall Street Icon: “You must get on the right side of this thing”
I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.
See More Headlines

HRTS ETF - Frequently Asked Questions

Tema Obesity & Cardiometabolic ETF's stock was trading at $30.61 on January 1st, 2024. Since then, HRTS shares have decreased by 4.8% and is now trading at $29.15.
View the best growth stocks for 2024 here
.

Shares of HRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tema Obesity & Cardiometabolic ETF investors own include Intuitive Surgical (ISRG), Adobe (ADBE), Accenture (ACN), Alpha Metallurgical Resources (AMR), Arista Networks (ANET), AppLovin (APP) and Arch Resources (ARCH).

Fund Details

Issuer
Fund Name
Tema Cardiovascular and Metabolics ETF
Tax Classification
Current Symbol
NYSEARCA:HRTS
Inception Date
1/1/2100
Fund Manager
N/A
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Benchmark
N/A
Category
Focus
Development Level
Region
Number of Holdings
40

Fund Statistics

Assets Under Management
$524,000.00
Average Daily Volume
$0.00
Discount/Premium
0.43%

Administrator, Advisor and Custodian

Administrator
N/A
Advisor
N/A
Custodian
N/A
Distributor
N/A
Transfer Agent
N/A
Trustee
N/A
Lead Market Maker
N/A

Miscellaneous

Beta
0.93
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Top 10 HRTS Holdings

HRTS Sector Exposure

HRTS Industry Exposure


This page (NYSEARCA:HRTS) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners